E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/15/2006 in the Prospect News Biotech Daily.

NxStage obtains $20 million credit facility

By Lisa Kerner

Erie, Pa., May 15 - NxStage Medical, Inc. obtained a $20 million credit facility from SVB Silicon Valley Bank, the commercial banking arm of SVB Financial Group, according to a company news release.

Proceeds from the financing will be used to provide additional working capital to finance installations of dialysis equipment in the field.

Located in Lawrence, Mass., NxStage is a medical device company develops, manufactures and markets dialysis systems for the treatment of end-stage renal disease and acute kidney failure.

Borrower:NxStage Medical, Inc.
Amount:$20 million
Issue:Credit facility
Maturity:2 years
Lender:SVB Silicon Valley Bank
Announcement date:May 15

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.